Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Departments of Pediatrics and Medicine, School of Medicine, University of Colorado, Aurora, Colorado, USA.
J Infect Dis. 2022 Sep 13;226(5):757-765. doi: 10.1093/infdis/jiac236.
Down syndrome (DS) is associated with an increased risk of infections attributed to immune defects. Whether individuals with DS are at an increased risk of severe coronavirus disease 2019 (COVID-19) remains unclear.
In a matched cohort study, we evaluated the risk of COVID-19 infection and severe COVID-19 disease in individuals with DS and their matched counterparts in a pre-COVID-19 vaccination period at Kaiser Permanente Southern California. Multivariable Cox proportion hazard regression was used to investigate associations between DS and risk of COVID-19 infection and severe COVID-19 disease.
Our cohort included 2541 individuals with DS and 10 164 without DS matched on age, sex, and race/ethnicity (51.6% female, 53.3% Hispanic, median age 25 years [interquartile range, 14-38]). Although the rate of COVID-19 infection in individuals with DS was 32% lower than their matched counterparts (adjusted hazard ratio [aHR], 0.68; 95% confidence interval [CI], .56-.83), the rate of severe COVID-19 disease was 6-fold higher (aHR, 6.14; 95% CI, 1.87-20.16).
Although the risk of COVID-19 infection is lower, the risk of severe disease is higher in individuals with DS compared with their matched counterparts. Better infection monitoring, early treatment, and promotion of vaccine for COVID-19 are warranted for DS populations.
唐氏综合征(DS)与免疫缺陷相关的感染风险增加有关。DS 个体患严重 2019 年冠状病毒病(COVID-19)的风险是否增加仍不清楚。
在一项匹配队列研究中,我们在 COVID-19 疫苗接种前时期,在 Kaiser Permanente Southern California 评估了 DS 个体及其匹配对照者 COVID-19 感染和严重 COVID-19 疾病的风险。使用多变量 Cox 比例风险回归来研究 DS 与 COVID-19 感染和严重 COVID-19 疾病风险之间的关联。
我们的队列包括 2541 名 DS 个体和 10164 名无 DS 个体,按年龄、性别和种族/族裔(51.6%为女性,53.3%为西班牙裔,中位年龄 25 岁[四分位间距,14-38])进行匹配。尽管 DS 个体的 COVID-19 感染率比其匹配对照者低 32%(调整后的危险比[aHR],0.68;95%置信区间[CI],0.56-0.83),但严重 COVID-19 疾病的发生率却高 6 倍(aHR,6.14;95%CI,1.87-20.16)。
与匹配对照者相比,DS 个体 COVID-19 感染的风险较低,但严重疾病的风险较高。需要对 DS 人群进行更好的感染监测、早期治疗和 COVID-19 疫苗推广。